Buyer for injectable drug manufacturer in Europe

Company to buy

• Size: Medium 
• Sales: 10 – 50 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business in Europe
• #CFIE PHB236

Overview of buyer for injectable drug manufacturer in Europe

This company is a European leader in pharmaceutical development and manufacturing. Primarily, it supports pharmaceutical companies in the development, manufacture, and packaging of their medicines.

Profile (strategy) of buyer for injectable drug manufacturer in Europe

As a contract development and manufacturing organization (CDMO), the company specializes in the development and production of small and medium series for the pharmaceutical industry. More specifically, it offers an agile range of services and products adapted to the needs of patients, including:

• Development of sterile injectable forms, including vials
• Freeze-drying (lyophilization) of sterile and non-sterile forms
• Development of cytotoxic injectable forms
• Development of non-sterile single-dose forms, including sachets, powder sticks, and liquid sticks
• Development of oral solid forms, including tablets, coated tablets, dragees, capsules, and soft gel capsules

Essentially, the company is committed to quality and innovation. In addition, it has a strong track record of success in developing and manufacturing high-quality pharmaceutical products, including sterile injectables, lyophilized products, and cytotoxic products. Further, it is also committed to sustainable development and has implemented several initiatives to reduce its environmental impact.

Altogether, the company operates 7 manufacturing plants in Europe, providing most of the dosage forms available on the market, including sterile vials. Notably, with a workforce of over 1,300 employees, these industrial sites generate an annual turnover of over 140 million euros.

Activities and products of suitable targets

Currently, the buyer seeks a target manufacturing company with expertise in injectable drugs. Ideally, the target should produce cytotoxics and other injectable drugs that are available in solutions and freeze-dried forms. For example, packaged in vials, ampoules, and pre-filled syringes. Overall, the acquisition of a manufacturing company with experience in related areas would be a strategic opportunity for the company. In particular, the company could expand its range of services and become an even more important player in the European market.

Highlights

• European leader in pharmaceutical development and manufacturing
• Strong focus on cytotoxic, sterile injectable, and lyophilized products
• Supports pharmaceutical companies in the development, manufacture, and packaging of their medicines
• Operates 7 manufacturing plants
• Annual turnover of 140 million EUR
• Offers an agile range of services and products adapted to the needs of patients
• Committed to quality and innovation
• Strong track record of success in developing and manufacturing high-quality pharmaceutical products

More information on this buyer for injectable drug manufacturer in Europe

Please get in touch if you are interested in learning more about this buyer for injectable drug manufacturer in Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.